We are constantly exploring opportunities by validating the science and assessing the commercial potential of new technologies.
At the moment, our portfolio comprise of the following technologies:
A project that is currently in the research stage, involves the measurement of fluid perfusion rates within tissues. This technology would enable clinicians to follow the course of physiological events where skin grafting was carried out, for example.
Physiological studies are also underway to measure pH directly in tissues. When pH begins to fall, there is a very urgent need to address the potentially catastrophic failure in tissue viability. Being able to determine the pH provides a very useful surrogate marker for both the metabolic viability of a tissue or organ and whether or not it is being adequately supplied with oxygen and nutrients.
If you would like to know more about any of the above technologies, please contact us.